Who Discovered GHK-Cu?
Short answer: Loren Pickart, then a biochemist at the University of California, San Francisco, isolated the tripeptide glycyl-L-histidyl-L-lysine from human plasma in 1973 while studying why plasma from young donors affected liver tissue differently from plasma from older donors. The copper complex, GHK-Cu, and its affinity for copper were characterised in the years that followed, and Pickart published on the peptide for the next five decades.
The discovery paper appeared in Nature New Biology in 1973. Pickart went on to found companies that put GHK-Cu into cosmetics, which is why much of the later literature carries his name and should be read with that in mind.
Independent groups — Maquart and colleagues in France among them — reported on the peptide in the 1980s and 1990s, and those papers are cited on their own pages.
REVIVE LAB UAE supplies the pack for laboratory research use only. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.
GHK-Cu Pack 50 mg — REVIVE LAB UAE
AED 425 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order GHK-Cu Pack UAE — Live Stock & Pricing
AED 425 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order GHK-Cu Pack UAE — Live Stock & Pricing
Research-Use Only Disclaimer: This page is published for laboratory and scientific research information purposes only. Nothing here constitutes medical advice, dosing guidance, or a therapeutic recommendation. Products supplied by REVIVE LAB UAE (revivelab.ae) — where applicable — are sold strictly as reference materials for research use, not for human or veterinary consumption. Buyers and readers are solely responsible for compliance with applicable UAE laws and institutional research ethics requirements.